Historical record - last NADAC effective date: 12/20/2023
Product Information
ESCITALOPRAM 5 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.0464 per EA under NDC 59746027901. Its NADAC has been published 525 times since Dec 11, 2013.
FDA first approved this application on Sep 12, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746027901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
12/20/2023
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA202280FDA Approved
9/12/2012
TE Code
AB
On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 5 MG TABLET has been published 525 times since Dec 11, 2013, and over the history we have for it it has declined 64.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0464 per EA |
|---|---|
| All-time high | $0.1852 (Mar 11, 2015) |
| All-time low | $0.0423 (Jan 18, 2023) |
| Median price | $0.0673 |
| Average price | $0.0877 |
| Largest weekly change | +44.7% (Jun 22, 2016) |
| Weeks tracked | 525 |
| Tracking since | Dec 11, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-3.7%
5Y
-21.4%
All
-64.3%
Last surveyed Dec 27, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.0464 per EA (NDC 59746027901), effective Dec 27, 2023.
How has the price of ESCITALOPRAM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has declined 64.3%. It has been tracked across 525 weekly CMS publications since Dec 11, 2013.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?
Since Dec 11, 2013, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0423 (Jan 18, 2023) to a high of $0.1852 (Mar 11, 2015), with a median of $0.0673 per EA.
Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESCITALOPRAM 5 MG TABLET, is $0.0412 per EA — about 11% below ESCITALOPRAM 5 MG TABLET.
Who manufactures ESCITALOPRAM 5 MG TABLET?
ESCITALOPRAM 5 MG TABLET (NDC 59746027901) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.